Login
Home / 006280.KS : KSC
Follow Compare
AI Analysis Fundamentals Valuation Video Analysis Similar
Quarterly Quarterly (TTM) Annually

AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

GC Biopharma Corp.

₩124900 -$34500.00 (-21.64%)
KSC · 15 Sep 2026 06:30 UTC
Previous Close
₩126600
Day Range
₩124800₩127400
Year Range
₩105900₩183800
Market Cap
1.43T
AVG Volume
52.88K
Trailing/Forward PE
-28.57/21.29
PEG ratio
0.39
Dividend Yield
1.20%
Next Earnings Date
2026-11-03
Primary Exchange
Korea ExchangeKR
Revenue (KRW)
0200B400B600B800B24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Net Income (KRW)
-100B-50B050B24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Operating Income (KRW)
-20B020B40B24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
EBITDA (KRW)
-20B020B40B60B80B24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Cash Flows (KRW)
-100B-50B050B100B24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
EPS (KRW)
-10000-50000500024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Expenses (KRW)
050B100B150B200BR&DSG&ACapex24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Cash & Debt (KRW)
0500B1T1.5TCashLong Term DebtShort Term Debt24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Debt ratios
02.557.51024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Margins
0%10%20%30%40%24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Return on Capital
-7.5%-5%-2.5%0%2.5%5%24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Shares Outstanding
05M10M15M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Dividends (KRW)
0500100015002000Dec 16Dec 17Dec 18Dec 19Dec 20Dec 21Dec 22Dec 23Dec 24Mar 26
Book Value Per Share (KRW)
010000020000030000024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Total Assets (KRW)
01T2T3T4T24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
PE Ratio
020406080100med 30.83Jan 23Apr 23Aug 23Nov 23Aug 25Dec 25Mar 26
Free Cash Flow Yield
-10%-5%0%5%med -4.5%Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
Price to Sales
0.60.811.21.4med 0.88Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
EV/EBITDA
1015202530med 23.26Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
Price/Operating Cashflow
0102030med 14.53Dec 22Apr 23Jul 23Nov 23Feb 26Jun 26Sep 26
Price to Book
0.811.21.41.6med 1.09Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
GC Biopharma Corp.
006280.KS
Stockpicker

Video analysis: 006280.KS

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.